Share Price and Basic Stock Data
Last Updated: January 23, 2026, 6:19 pm
| PEG Ratio | 0.10 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Murae Organisor Ltd operates in the pharmaceuticals sector, reporting a market capitalization of ₹47.0 Cr. The company’s stock price stood at ₹0.23, reflecting the ongoing challenges within the industry. Revenue trends indicate significant volatility; sales recorded in the fiscal year ending March 2025 surged to ₹855 Cr, a remarkable increase from merely ₹14 Cr in the prior fiscal year. This growth trajectory is notable, especially considering the historical sales figures which have fluctuated widely, from ₹21 Cr in FY 2022 to a peak of ₹51 Cr in FY 2019. The trailing twelve months (TTM) sales reached ₹859 Cr, showcasing a consistent upward trend. However, recent quarterly sales data from September 2023 showed a steep decline to ₹0.43 Cr, indicating potential operational issues or market challenges that need addressing. The company’s ability to navigate these fluctuations will be critical for sustaining growth.
Profitability and Efficiency Metrics
The profitability metrics of Murae Organisor Ltd present a mixed picture. The company reported a net profit of ₹15 Cr, with an operating profit margin (OPM) of 23.56%. However, the historical OPM figures show considerable volatility, with margins fluctuating significantly across quarters, including negative margins in several periods. For instance, the OPM reached as high as 79.08% in March 2023 but dropped to -220.93% by September 2023. The return on equity (ROE) was reported at 5.69%, while the return on capital employed (ROCE) stood at 4.20%. These figures suggest that while Murae is generating profits, the efficiency of its capital utilization remains suboptimal compared to industry standards, which often exceed 10% for ROCE in the pharmaceutical sector. The company’s ability to manage costs effectively and enhance operational efficiency will be vital for improving profitability.
Balance Sheet Strength and Financial Ratios
Murae Organisor Ltd’s balance sheet reveals significant leverage, with total borrowings amounting to ₹213 Cr against reserves of ₹23 Cr. This presents a concerning debt-to-equity dynamic, especially given the company’s historical context, where borrowings were negligible in earlier years. The interest coverage ratio (ICR) stood at 3.63x, indicating that the company can cover its interest obligations comfortably, although the high level of debt raises concerns about long-term sustainability. The price-to-book value (P/BV) ratio is recorded at 2.02x, suggesting that the market values the company at a premium to its book value, yet this premium must be justified by consistent profitability and growth. Current liabilities and overall financial obligations appear manageable, but the increasing borrowings trend poses risks if market conditions worsen or operational performance declines.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Murae Organisor Ltd shows a strong public presence, with public shareholders constituting 99.99% of the ownership structure as of December 2023. The number of shareholders has risen dramatically over the past year, from 31,093 in December 2022 to 133,664 by June 2025, indicating growing investor interest. However, the absence of institutional investors (FIIs and DIIs) raises questions about the stock’s stability and long-term investor confidence. While the increase in retail shareholders suggests speculative interest, it may also reflect a lack of institutional backing, which typically provides stability and confidence in the stock. This retail-driven ownership could lead to volatility in the stock price, particularly in response to market sentiments or operational performance fluctuations.
Outlook, Risks, and Final Insight
Looking ahead, Murae Organisor Ltd faces both opportunities and risks. The substantial increase in sales for FY 2025 suggests potential for growth if the company can leverage this momentum effectively. However, challenges such as high leverage and fluctuating profitability metrics could hinder sustained performance. The reliance on public shareholders may lead to volatility, especially if market conditions shift unfavorably. Additionally, the company’s operational efficiency needs improvement to meet industry standards. A focus on cost management and strategic growth initiatives will be crucial. Overall, Murae must navigate its financial challenges while capitalizing on its growth potential to build a sustainable business model in the competitive pharmaceutical landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 126 Cr. | 99.9 | 197/84.3 | 27.8 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 3,463 Cr. | 318 | 479/192 | 71.7 | 24.3 | 0.21 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.6 Cr. | 43.9 | 87.8/37.2 | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 61.0 Cr. | 41.7 | 43.4/17.0 | 145 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 19,525.73 Cr | 1,087.19 | 47.43 | 202.32 | 0.38% | 16.29% | 15.20% | 6.10 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.28 | 7.11 | 1.17 | 1.53 | 1.71 | 0.43 | 0.40 | 0.86 | 0.23 | 58.01 | 281.05 | 515.53 | 3.99 |
| Expenses | 4.76 | 7.05 | 1.04 | 0.32 | 2.37 | 1.38 | 0.34 | -0.44 | 0.47 | 56.88 | 275.79 | 511.64 | 3.05 |
| Operating Profit | -0.48 | 0.06 | 0.13 | 1.21 | -0.66 | -0.95 | 0.06 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 | 0.94 |
| OPM % | -11.21% | 0.84% | 11.11% | 79.08% | -38.60% | -220.93% | 15.00% | 151.16% | -104.35% | 1.95% | 1.87% | 0.75% | 23.56% |
| Other Income | 0.87 | 0.00 | 1.40 | 0.00 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00 |
| Interest | 0.00 | 0.00 | 0.14 | 0.15 | 0.26 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.37 | 0.04 | 1.36 | 1.03 | -0.28 | -0.98 | 0.04 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 | 9.94 |
| Tax % | 0.00% | 0.00% | 0.00% | 74.76% | 0.00% | -11.22% | 0.00% | 10.00% | 0.00% | 19.47% | 23.76% | 26.74% | 25.15% |
| Net Profit | 0.36 | 0.04 | 1.37 | 0.26 | -0.28 | -0.87 | 0.04 | 1.17 | -0.24 | 0.90 | 4.01 | 2.85 | 7.44 |
| EPS in Rs | 0.00 | 0.00 | 0.02 | 0.00 | -0.00 | -0.01 | 0.00 | 0.02 | -0.00 | 0.00 | 0.02 | 0.01 | 0.04 |
Last Updated: December 27, 2025, 4:37 am
Below is a detailed analysis of the quarterly data for Murae Organisor Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3.99 Cr.. The value appears to be declining and may need further review. It has decreased from 515.53 Cr. (Mar 2025) to 3.99 Cr., marking a decrease of 511.54 Cr..
- For Expenses, as of Jun 2025, the value is 3.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 511.64 Cr. (Mar 2025) to 3.05 Cr., marking a decrease of 508.59 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.94 Cr.. The value appears to be declining and may need further review. It has decreased from 3.89 Cr. (Mar 2025) to 0.94 Cr., marking a decrease of 2.95 Cr..
- For OPM %, as of Jun 2025, the value is 23.56%. The value appears strong and on an upward trend. It has increased from 0.75% (Mar 2025) to 23.56%, marking an increase of 22.81%.
- For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 9.94 Cr.. The value appears strong and on an upward trend. It has increased from 3.89 Cr. (Mar 2025) to 9.94 Cr., marking an increase of 6.05 Cr..
- For Tax %, as of Jun 2025, the value is 25.15%. The value appears to be improving (decreasing) as expected. It has decreased from 26.74% (Mar 2025) to 25.15%, marking a decrease of 1.59%.
- For Net Profit, as of Jun 2025, the value is 7.44 Cr.. The value appears strong and on an upward trend. It has increased from 2.85 Cr. (Mar 2025) to 7.44 Cr., marking an increase of 4.59 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.04. The value appears strong and on an upward trend. It has increased from 0.01 (Mar 2025) to 0.04, marking an increase of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 855 | 859 |
| Expenses | 0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 845 | 847 |
| Operating Profit | 0 | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -0 | 10 | 11 |
| OPM % | 2% | 3% | 2% | 4% | 7% | 2% | -19% | -21% | 7% | -15% | 1% | 1% | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 1 | 0 | 9 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 | 20 |
| Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | 25% | ||
| Net Profit | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 | 15 |
| EPS in Rs | 0.07 | 0.11 | 0.23 | 0.42 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 | 0.04 | 0.07 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 0.00% | -100.00% | 0.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.00% | -100.00% | 100.00% | -100.00% |
Murae Organisor Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2018-2019 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 58% |
| 5 Years: | 73% |
| 3 Years: | 244% |
| TTM: | 44618% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 33% |
| 3 Years: | 50% |
| TTM: | 15100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -22% |
| 3 Years: | -7% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: December 10, 2025, 4:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 186 |
| Reserves | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 23 |
| Borrowings | 0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 213 |
| Other Liabilities | 0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 231 |
| Total Liabilities | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 652 |
| Total Assets | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
Below is a detailed analysis of the balance sheet data for Murae Organisor Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 186.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2024) to 186.00 Cr., marking an increase of 137.00 Cr..
- For Reserves, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 17.00 Cr..
- For Borrowings, as of Mar 2025, the value is 213.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 0.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 213.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 231.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 64.00 Cr. (Mar 2024) to 231.00 Cr., marking an increase of 167.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 652.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 120.00 Cr. (Mar 2024) to 652.00 Cr., marking an increase of 532.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 652.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2024) to 652.00 Cr., marking an increase of 532.00 Cr..
- For Total Assets, as of Mar 2025, the value is 652.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2024) to 652.00 Cr., marking an increase of 532.00 Cr..
However, the Borrowings (213.00 Cr.) are higher than the Reserves (23.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -1.00 | -1.00 | -2.00 | -5.00 | -7.00 | -8.00 | -19.00 | -13.00 | -8.00 | 0.00 | -203.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,225 | 108 | |
| Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | 1 | |
| Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | 85 | |
| Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,657 | 24 | |
| Working Capital Days | 81 | 24 | 34 | 64 | 57 | 79 | 143 | 279 | 472 | 5,034 | 160 | |
| ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 20 | Mar 19 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.95 | 53.84 |
| Diluted EPS (Rs.) | 2.95 | 53.83 |
| Cash EPS (Rs.) | 3.11 | 55.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.51 | 192.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.51 | 192.64 |
| Revenue From Operations / Share (Rs.) | 89.35 | 1642.90 |
| PBDIT / Share (Rs.) | 5.70 | 108.68 |
| PBIT / Share (Rs.) | 5.54 | 107.46 |
| PBT / Share (Rs.) | 3.97 | 73.78 |
| Net Profit / Share (Rs.) | 2.94 | 53.84 |
| NP After MI And SOA / Share (Rs.) | 2.95 | 53.84 |
| PBDIT Margin (%) | 6.37 | 6.61 |
| PBIT Margin (%) | 6.19 | 6.54 |
| PBT Margin (%) | 4.44 | 4.49 |
| Net Profit Margin (%) | 3.29 | 3.27 |
| NP After MI And SOA Margin (%) | 3.30 | 3.27 |
| Return on Networth / Equity (%) | 12.55 | 27.94 |
| Return on Capital Employeed (%) | 21.50 | 38.80 |
| Return On Assets (%) | 4.65 | 7.14 |
| Long Term Debt / Equity (X) | 0.09 | 0.43 |
| Total Debt / Equity (X) | 0.60 | 1.40 |
| Current Ratio (X) | 1.58 | 1.55 |
| Quick Ratio (X) | 0.96 | 0.80 |
| Interest Coverage Ratio (X) | 3.63 | 3.23 |
| Interest Coverage Ratio (Post Tax) (X) | 2.88 | 2.60 |
| Enterprise Value (Cr.) | 37.89 | 0.00 |
| EV / Net Operating Revenue (X) | 0.68 | 0.00 |
| EV / EBITDA (X) | 10.78 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.00 |
| Price / BV (X) | 2.02 | 0.00 |
| Price / Net Operating Revenue (X) | 0.53 | 0.00 |
| EarningsYield | 0.06 | 0.00 |
After reviewing the key financial ratios for Murae Organisor Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 20, the value is 2.95. This value is below the healthy minimum of 5. It has decreased from 53.84 (Mar 19) to 2.95, marking a decrease of 50.89.
- For Diluted EPS (Rs.), as of Mar 20, the value is 2.95. This value is below the healthy minimum of 5. It has decreased from 53.83 (Mar 19) to 2.95, marking a decrease of 50.88.
- For Cash EPS (Rs.), as of Mar 20, the value is 3.11. This value is within the healthy range. It has decreased from 55.06 (Mar 19) to 3.11, marking a decrease of 51.95.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 23.51. It has decreased from 192.64 (Mar 19) to 23.51, marking a decrease of 169.13.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 23.51. It has decreased from 192.64 (Mar 19) to 23.51, marking a decrease of 169.13.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 89.35. It has decreased from 1,642.90 (Mar 19) to 89.35, marking a decrease of 1,553.55.
- For PBDIT / Share (Rs.), as of Mar 20, the value is 5.70. This value is within the healthy range. It has decreased from 108.68 (Mar 19) to 5.70, marking a decrease of 102.98.
- For PBIT / Share (Rs.), as of Mar 20, the value is 5.54. This value is within the healthy range. It has decreased from 107.46 (Mar 19) to 5.54, marking a decrease of 101.92.
- For PBT / Share (Rs.), as of Mar 20, the value is 3.97. This value is within the healthy range. It has decreased from 73.78 (Mar 19) to 3.97, marking a decrease of 69.81.
- For Net Profit / Share (Rs.), as of Mar 20, the value is 2.94. This value is within the healthy range. It has decreased from 53.84 (Mar 19) to 2.94, marking a decrease of 50.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 2.95. This value is within the healthy range. It has decreased from 53.84 (Mar 19) to 2.95, marking a decrease of 50.89.
- For PBDIT Margin (%), as of Mar 20, the value is 6.37. This value is below the healthy minimum of 10. It has decreased from 6.61 (Mar 19) to 6.37, marking a decrease of 0.24.
- For PBIT Margin (%), as of Mar 20, the value is 6.19. This value is below the healthy minimum of 10. It has decreased from 6.54 (Mar 19) to 6.19, marking a decrease of 0.35.
- For PBT Margin (%), as of Mar 20, the value is 4.44. This value is below the healthy minimum of 10. It has decreased from 4.49 (Mar 19) to 4.44, marking a decrease of 0.05.
- For Net Profit Margin (%), as of Mar 20, the value is 3.29. This value is below the healthy minimum of 5. It has increased from 3.27 (Mar 19) to 3.29, marking an increase of 0.02.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is 3.30. This value is below the healthy minimum of 8. It has increased from 3.27 (Mar 19) to 3.30, marking an increase of 0.03.
- For Return on Networth / Equity (%), as of Mar 20, the value is 12.55. This value is below the healthy minimum of 15. It has decreased from 27.94 (Mar 19) to 12.55, marking a decrease of 15.39.
- For Return on Capital Employeed (%), as of Mar 20, the value is 21.50. This value is within the healthy range. It has decreased from 38.80 (Mar 19) to 21.50, marking a decrease of 17.30.
- For Return On Assets (%), as of Mar 20, the value is 4.65. This value is below the healthy minimum of 5. It has decreased from 7.14 (Mar 19) to 4.65, marking a decrease of 2.49.
- For Long Term Debt / Equity (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.43 (Mar 19) to 0.09, marking a decrease of 0.34.
- For Total Debt / Equity (X), as of Mar 20, the value is 0.60. This value is within the healthy range. It has decreased from 1.40 (Mar 19) to 0.60, marking a decrease of 0.80.
- For Current Ratio (X), as of Mar 20, the value is 1.58. This value is within the healthy range. It has increased from 1.55 (Mar 19) to 1.58, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 20, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.80 (Mar 19) to 0.96, marking an increase of 0.16.
- For Interest Coverage Ratio (X), as of Mar 20, the value is 3.63. This value is within the healthy range. It has increased from 3.23 (Mar 19) to 3.63, marking an increase of 0.40.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 2.88. This value is below the healthy minimum of 3. It has increased from 2.60 (Mar 19) to 2.88, marking an increase of 0.28.
- For Enterprise Value (Cr.), as of Mar 20, the value is 37.89. It has increased from 0.00 (Mar 19) to 37.89, marking an increase of 37.89.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 19) to 0.68, marking an increase of 0.68.
- For EV / EBITDA (X), as of Mar 20, the value is 10.78. This value is within the healthy range. It has increased from 0.00 (Mar 19) to 10.78, marking an increase of 10.78.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 19) to 0.53, marking an increase of 0.53.
- For Price / BV (X), as of Mar 20, the value is 2.02. This value is within the healthy range. It has increased from 0.00 (Mar 19) to 2.02, marking an increase of 2.02.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 19) to 0.53, marking an increase of 0.53.
- For EarningsYield, as of Mar 20, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 19) to 0.06, marking an increase of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Murae Organisor Ltd:
- Net Profit Margin: 3.29%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.5% (Industry Average ROCE: 16.29%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.55% (Industry Average ROE: 15.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 2.96 (Industry average Stock P/E: 47.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.29%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | Block-B, Office No.702, Dev Auram, Anandnagar Char Rasta, Ahmedabad Gujarat 380015 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chinmay Shrikant Pradhan | Managing Director |
| Mr. Nitinkumar Ashokkumar Tomar | Non Executive Director |
| Mr. Krunalbhai Desai | Non Executive Director |
| Mr. Ankit Patel | Independent Director |
| Mr. Mayur Sureshkumar Vyas | Independent Director |
| Ms. Vaishaliben Patel | Independent Director |
FAQ
What is the intrinsic value of Murae Organisor Ltd?
Murae Organisor Ltd's intrinsic value (as of 25 January 2026) is ₹0.18 which is 18.18% lower the current market price of ₹0.22, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹45.0 Cr. market cap, FY2025-2026 high/low of ₹1.12/0.22, reserves of ₹23 Cr, and liabilities of ₹652 Cr.
What is the Market Cap of Murae Organisor Ltd?
The Market Cap of Murae Organisor Ltd is 45.0 Cr..
What is the current Stock Price of Murae Organisor Ltd as on 25 January 2026?
The current stock price of Murae Organisor Ltd as on 25 January 2026 is ₹0.22.
What is the High / Low of Murae Organisor Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Murae Organisor Ltd stocks is ₹1.12/0.22.
What is the Stock P/E of Murae Organisor Ltd?
The Stock P/E of Murae Organisor Ltd is 2.96.
What is the Book Value of Murae Organisor Ltd?
The Book Value of Murae Organisor Ltd is 1.02.
What is the Dividend Yield of Murae Organisor Ltd?
The Dividend Yield of Murae Organisor Ltd is 0.00 %.
What is the ROCE of Murae Organisor Ltd?
The ROCE of Murae Organisor Ltd is 4.20 %.
What is the ROE of Murae Organisor Ltd?
The ROE of Murae Organisor Ltd is 5.69 %.
What is the Face Value of Murae Organisor Ltd?
The Face Value of Murae Organisor Ltd is 1.00.